comparemela.com

Latest Breaking News On - Sei investments co - Page 2 : comparemela.com

Pathstone Holdings LLC Makes New $37 97 Million Investment in iShares Russell 2000 Value ETF (NYSEARCA:IWN)

Pathstone Holdings LLC bought a new stake in iShares Russell 2000 Value ETF (NYSEARCA:IWN – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 244,423 shares of the company’s stock, valued at approximately $37,966,000. Pathstone Holdings LLC owned approximately 0.30% of […]

Pathstone Holdings LLC Purchases New Shares in Vanguard Small-Cap Growth ETF (NYSEARCA:VBK)

Pathstone Holdings LLC purchased a new stake in Vanguard Small-Cap Growth ETF (NYSEARCA:VBK – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 138,458 shares of the company’s stock, valued at approximately $33,474,000. Pathstone Holdings LLC owned 0.22% of Vanguard Small-Cap […]

Continuum Advisory LLC Sells 3,201 Shares of Vanguard Tax-Exempt Bond ETF (NYSEARCA:VTEB)

Continuum Advisory LLC cut its holdings in Vanguard Tax-Exempt Bond ETF (NYSEARCA:VTEB – Free Report) by 6.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 44,255 shares of the company’s stock after selling 3,201 shares during the period. Continuum Advisory LLC’s holdings in Vanguard Tax-Exempt […]

Mairs & Power Inc Has $237 61 Million Holdings in Bio-Techne Co (NASDAQ:TECH)

Mairs & Power Inc. raised its position in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 0.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,079,483 shares of the biotechnology company’s stock after buying an additional 25,903 shares during the quarter. […]

Mairs & Power Inc Has $237 61 Million Holdings in Bio-Techne Co (NASDAQ:TECH)

Mairs & Power Inc. raised its position in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 0.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,079,483 shares of the biotechnology company’s stock after buying an additional 25,903 shares during the quarter. […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.